WPD PharmaceuticalsS.A.Active
Research and experimental development on biotechnology
KRS: 0001106865 NIP: 7011206453 REGON: 52869102400000
Overview
Registry date
2024-05-23
Share capital
$49,547.54
Activity description
Wpd Pharmaceuticals is focused on developing biological and chemical molecules for targeted therapy aimed at treating brain glioma and other central nervous system cancers. The company is based in Warsaw, Poland.
Registered address
Ul. Żwirki I Wigury 101, 02-089 Warszawa, Poland
Website
wpdpharmaceuticals.pl/contact/wpdsa/Website active
Electronic delivery address
AE:PL-30664-56884-UJSTH-21
Industry
Bank accounts
Registered as a VAT taxpayer on 2024-07-01.Active
- 07 1050 1298 1000 0090 8364 2224
- 46 1050 1298 1000 0090 3303 8465
Authorized Representatives
Ownership
Subsidiaries
| Name | Shares | Share value | % in company | |
|---|---|---|---|---|
| WPD Pharmaceuticalssp. z o.o. | 130,098 | 1,757,131.28 USD | 100% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| FcbiotechS.A. | $148,945.77 | fcbiotech.pl | |
| UveraS.A. | $155,384.29 | uvera.eu | |
| PellicarnosS.A. | $135,043.43 | pellicarnos.com | |
| IntelliseqS.A. | $111,419.60 | intelliseq.pl | |
| DigitmedS.A. | $64,087.41 | digitmed.pl | |
| InventroS.A. | $12,176.61 | inventro.co | |
| Oncotherics PolandS.A. | $7,565.33 | oncotherics.com | |
| ArthecS.A. | $6,901.64 | arthec.eu | |
| 4cell TherapiesS.A. | $838.64 | 4celltherapies.com | |
| UrtesteS.A. | $324.85 | urteste.com |
Change history
| Event | Details | Date | |
|---|---|---|---|
| Share capital change | 166925.00 PLN → 183425.00 PLN | 2026-04-29 |
FAQ
Last updated: 2026-06-15